TY - JOUR
T1 - Predicting Protein-Ligand Docking Structure with Graph Neural Network
AU - Jiang, Huaipan
AU - Wang, Jian
AU - Cong, Weilin
AU - Huang, Yihe
AU - Ramezani, Morteza
AU - Sarma, Anup
AU - Dokholyan, Nikolay V.
AU - Mahdavi, Mehrdad
AU - Kandemir, Mahmut T.
N1 - Funding Information:
We acknowledge sponsorship from the National Science Foundation and the National Institutes for Health. H. Jiang, W. Cong, Y. Huang, M. Ramezani, M. T. Kandemir, and M. Mahdavi are supported by NSF Grants 1629129, 1629915, 1931531, 2008398, and 2028929. A. Sarma is supported by NSF Grant 1955815. N. V. Dokholyan and J. Wang are supported by the National Institutes of Health (NIH) Grants 1R01AG065294, 1R35GM134864, and 1RF1AG071675 and the Passan Foundation (to N. V. Dokholyan). This project is also partially supported by the National Center for Advancing Translational Sciences, NIH, through Grant UL1 TR002014. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of NSF or NIH. a
Publisher Copyright:
© 2022 American Chemical Society. All rights reserved.
PY - 2022/6/27
Y1 - 2022/6/27
N2 - Modern day drug discovery is extremely expensive and time consuming. Although computational approaches help accelerate and decrease the cost of drug discovery, existing computational software packages for docking-based drug discovery suffer from both low accuracy and high latency. A few recent machine learning-based approaches have been proposed for virtual screening by improving the ability to evaluate protein-ligand binding affinity, but such methods rely heavily on conventional docking software to sample docking poses, which results in excessive execution latencies. Here, we propose and evaluate a novel graph neural network (GNN)-based framework, MedusaGraph, which includes both pose-prediction (sampling) and pose-selection (scoring) models. Unlike the previous machine learning-centric studies, MedusaGraph generates the docking poses directly and achieves from 10 to 100 times speedup compared to state-of-the-art approaches, while having a slightly better docking accuracy.
AB - Modern day drug discovery is extremely expensive and time consuming. Although computational approaches help accelerate and decrease the cost of drug discovery, existing computational software packages for docking-based drug discovery suffer from both low accuracy and high latency. A few recent machine learning-based approaches have been proposed for virtual screening by improving the ability to evaluate protein-ligand binding affinity, but such methods rely heavily on conventional docking software to sample docking poses, which results in excessive execution latencies. Here, we propose and evaluate a novel graph neural network (GNN)-based framework, MedusaGraph, which includes both pose-prediction (sampling) and pose-selection (scoring) models. Unlike the previous machine learning-centric studies, MedusaGraph generates the docking poses directly and achieves from 10 to 100 times speedup compared to state-of-the-art approaches, while having a slightly better docking accuracy.
UR - http://www.scopus.com/inward/record.url?scp=85133102218&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133102218&partnerID=8YFLogxK
U2 - 10.1021/acs.jcim.2c00127
DO - 10.1021/acs.jcim.2c00127
M3 - Review article
C2 - 35699430
AN - SCOPUS:85133102218
SN - 1549-9596
VL - 62
SP - 2923
EP - 2932
JO - Journal of Chemical Information and Modeling
JF - Journal of Chemical Information and Modeling
IS - 12
ER -